179 related articles for article (PubMed ID: 10770449)
1. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
Roy-Byrne PP; Pages KP; Russo JE; Jaffe C; Blume AW; Kingsley E; Cowley DS; Ries RK
J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
[TBL] [Abstract][Full Text] [Related]
2. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Gelenberg AJ; Trivedi MH; Rush AJ; Thase ME; Howland R; Klein DN; Kornstein SG; Dunner DL; Markowitz JC; Hirschfeld RM; Keitner GI; Zajecka J; Kocsis JH; Russell JM; Miller I; Manber R; Arnow B; Rothbaum B; Munsaka M; Banks P; Borian FE; Keller MB
Biol Psychiatry; 2003 Oct; 54(8):806-17. PubMed ID: 14550680
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
[TBL] [Abstract][Full Text] [Related]
4. Nefazodone treatment of comorbid alcohol dependence and major depression.
Hernandez-Avila CA; Modesto-Lowe V; Feinn R; Kranzler HR
Alcohol Clin Exp Res; 2004 Mar; 28(3):433-40. PubMed ID: 15084901
[TBL] [Abstract][Full Text] [Related]
5. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
[TBL] [Abstract][Full Text] [Related]
6. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
Lespérance F; Frasure-Smith N; Laliberté MA; White M; Lafontaine S; Calderone A; Talajic M; Rouleau JL
Can J Psychiatry; 2003 Nov; 48(10):695-701. PubMed ID: 14674053
[TBL] [Abstract][Full Text] [Related]
7. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
Feiger AD; Bielski RJ; Bremner J; Heiser JF; Trivedi M; Wilcox CS; Roberts DL; Kensler TT; McQuade RD; Kaplita SB; Archibald DG
Int Clin Psychopharmacol; 1999 Jan; 14(1):19-28. PubMed ID: 10221638
[TBL] [Abstract][Full Text] [Related]
9. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
Manber R; Rush AJ; Thase ME; Amow B; Klein D; Trivedi MH; Korenstein SG; Markowitz JC; Dunner DL; Munsaka M; Borian FE; Martin ; Keller B
Sleep; 2003 Mar; 26(2):130-6. PubMed ID: 12683470
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
[TBL] [Abstract][Full Text] [Related]
12. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
13. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D
Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
Elliott AJ; Russo J; Bergam K; Claypoole K; Uldall KK; Roy-Byrne PP
J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB
J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
[TBL] [Abstract][Full Text] [Related]
16. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Schatzberg AF; Rush AJ; Arnow BA; Banks PL; Blalock JA; Borian FE; Howland R; Klein DN; Kocsis JH; Kornstein SG; Manber R; Markowitz JC; Miller I; Ninan PT; Rothbaum BO; Thase ME; Trivedi MH; Keller MB
Arch Gen Psychiatry; 2005 May; 62(5):513-20. PubMed ID: 15867104
[TBL] [Abstract][Full Text] [Related]
17. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
[TBL] [Abstract][Full Text] [Related]
18. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.
Sánchez-Lacay JA; Lewis-Fernández R; Goetz D; Blanco C; Salmán E; Davies S; Liebowitz M
Depress Anxiety; 2001; 13(3):118-24. PubMed ID: 11387731
[TBL] [Abstract][Full Text] [Related]
19. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
Keller MB; McCullough JP; Klein DN; Arnow B; Dunner DL; Gelenberg AJ; Markowitz JC; Nemeroff CB; Russell JM; Thase ME; Trivedi MH; Zajecka J
N Engl J Med; 2000 May; 342(20):1462-70. PubMed ID: 10816183
[TBL] [Abstract][Full Text] [Related]
20. A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
Mischoulon D; Opitz G; Kelly K; Fava M; Rosenbaum JF
Depress Anxiety; 2004; 19(1):43-50. PubMed ID: 14978785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
